Eli Lilly and Company and UNICEF have announced a landmark global partnership aimed at improving healthcare access and disease prevention for millions of children and adolescents worldwide. The six-year initiative will focus on strengthening healthcare systems across 21 low- and middle-income countries, with special attention to non-communicable diseases such as diabetes, respiratory illnesses, congenital heart conditions and obesity.
As part of the collaboration, Eli Lilly will invest $50 million to support early diagnosis, healthcare worker training, community-based care and long-term disease management programs. The initiative is expected to benefit more than 30 million children, caregivers and young people between 2026 and 2032.
Both organizations emphasized the importance of integrating child-focused preventive healthcare into routine medical services to create stronger and more sustainable health systems. The partnership reflects a growing global effort to ensure that children, regardless of geography or income, have access to healthier futures and quality healthcare support from an early age.
By Arundhuti Chatterjee & Sharon Bose
